20020 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Method of Treating Psoriasis with Anti-IL23 Specific Antibody
#6302Anti-PHF-tau antibodies and uses thereof
#6303Methods of treating viral infections by administering an antibody preparation comprising IGG, IGA and IGM
#6304HIV vaccine formulation
#6305Co-crystal of sorafenib derivatives and process for preparation thereof
#6306Near infrared fluorescent dyes, formulations and related methods
#6307ADENO-ASSOCIATED VIRUS VARIANT CAPSIDS AND METHODS OF USE THEREOF
#6308ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER
#6309BI-FUNCTIONAL ALLOSTERIC PROTEIN-DRUG MOLECULES FOR TARGETED THERAPY
#6310PEGYLATED PORCINE INTERFERON AND METHODS OF USE THEREOF
#6311STABILIZED FACTOR IX FORMULATIONS CONTAINING TREHALOSE
#6312Method for inactivating Zika virus and for determining the completeness of inactivation
#6313Zika vaccines and immunogenic compositions, and methods of using the same
#6314COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF
#6315Skin therapeutics
#6316Pharmaceutical composition comprising recombinant hGH for the treatment of growth hormone deficiency
#6317GHRH or analogues thereof for use in treatment of hepatic disease
#6318TREATMENT OF INTERVERTEBRAL DISC DEGENERATION
#6319Genome editing of graft-derived T-cells for post-transplant immunotherapy
#6320Methods and compositions for treating stroke
#6321COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#6322Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)
#6323EXTENDED RELEASE FORMULATIONS FOR INTRA-ARTICULAR APPLICATIONS
#6324Androgen Receptor Modulator And Uses Thereof
#6325INJECTABLE ISOXAZOLINE PHARMACEUTICAL COMPOSITIONS AND THEIR USE AGAINST PARASITE INFESTATION
#6326Methods of treating cancer
#6327High concentration local anesthetic formulations
#6328Methods for treatment of Duchenne muscular dystrophy with follistatin polypeptides
#6329Microbial compositions and methods of use for improving milk production
#6330Methods of use of emulsion formulations of an NK-1 receptor antagonist
#6331Carboxyalkyl chitosan
#6332METHODS OF ADMINISTERING ANTI-CD38 ANTIBODY
#6333Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody
#6334Method of treating ocular conditions by administering an antibody that activates Tie2 and binds VEGF
#6335Method of treating inflammatory bowel disease
#6336TRUNCATED CARTILAGE-HOMING PEPTIDES AND PEPTIDE COMPLEXES AND METHODS OF USE THEREOF
#6337Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders
#6338NOBLE METAL-COATED MECHANORESPONSIVE VESICLES
#6339Biocampatible and Biodegradable Anionic Hydrogel System
#6340METHOD OF TREATING CANCER BY TARGETING MYELOID-DERIVED SUPPRESSOR CELLS
#6341METHODS OF SENSITIZING TUMORS TO TREATMENT WITH IMMUNE CHECKPOINT INHIBITORS
#6342SLC45A2 PEPTIDES FOR IMMUNOTHERAPY
#6343Treatment of neuronal ceroid lipofuscinosis
#6344ALKALINE PHOSPHATASE POLYPEPTIDES AND METHODS OF USE THEREOF
#6345RAPID-ACTING INSULIN COMPOSITIONS
#6346Method of treating melanocortin-4 receptor pathway-associated disorders
#6347SUSTAINED RELEASE PEPTIDE FORMULATIONS
#6348COMBINED USE OF SQUIRREL POXVIRUS AND MYXOMA POXVIRUS, FOR TREATING CANCER
#6349Use of Oncolytic Herpes Simplex Virus, Alone or in Combination with Immune Check-Point Inhibitor, in the Treatment of Cancer
#6350Compositions and methods of modulating HIF-2A to improve muscle generation and repair
#6351Conjugated Antisense Compounds for Use in Therapy
#6352POLYNUCLEOTIDE AGENTS TARGETING ANGIOTENSINOGEN (AGT) AND METHODS OF USE THEREOF
#6353Composition and method for treating muscle cramps containing choline alfoscerate as active ingredient
#6354Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide
#6355Concentrated Fulvestrant Compositions
#6356Use of inhibitors of Brutons tyrosine kinase (Btk)
#6357COMBINATION OF ANTI-CD20 ANTIBODY, P13 KINASE-DELTA SELECTIVE INHIBITOR, AND BTK INHIBITOR TO TREAT B-CELL PROLIFERATIVE DISORDERS
#6358Storage-stable ready-to-use injectable formulations of Trabectedin
#6359Treatment and management of augmentation in restless legs syndrome
#6360Methods and compositions for treating edema refractory to oral diuretics
#6361PROCESS FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS
#6362Oleogel compositions for retinal drug delivery
#6363NEONATAL PARENTERAL NUTRITION FORMULATIONS
#6364Compositions and methods for delivery of AAV
#6365METHODS AND COMPOSITIONS FOR TREATING A PROPROTEIN CONVERTASE SUBTILISIN KEXIN (PCSK9) GENE-ASSOCIATED DISORDER
#6366Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
#6367COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#6368PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA SELECTIVE AGONISTS FOR INHIBITION OF RETINAL PIGMENT EPITHELIUM DEGENERATION OR GEOGRAPHIC ATROPHY
#6369Magnesium phosphate hydrogels
#6370Methods for treating or alleviating a bone-loss related disease or condition by administering a nucleic acid encoding a discoidin domain receptor 1 (DDR1) protein
#6371Adeno-associated virus variant capsids and methods of use thereof
#6372Treatment of severe community acquired pneumonia
#6373Platform for generating safe cell therapeutics
#6374Methods for Improving Leptin Sensitivity for the Treatment of Obesity and Diabetes
#6375CHIMERIC VSV VIRUS COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OF CANCER
#6376CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY
#6377Compositions of hyaluronan with high elasticity and uses thereof
#6378Methods for the use of 5′-adenosine diphosphate ribose (ADPR)
#6379KITS FOR PREVENTING AND TREATING EBOLA
#6380Isomorphs of Remdesivir and methods for synthesis of same
#6381COMPOSITION FOR SUBCUTANEOUS INJECTION, CONTAINING DEOXYCHOLIC ACID, AND PREPARATION METHOD THEREFOR
#6382Methods of treating cancer
#6383EPICHAPEROME INHIBITOR THERAPY FOR TRAUMATIC BRAIN INJURY AND SEQUELAE THEREOF
#6384Hydrazone derivatives for preventing or treating EBV-related cancers
#6385DEPOT ADMINISTRATION OF ILOPERIDONE
#6386(S)-3-[1-methylpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a parenteral administration and a process for the preparation of an injectable substance
#6387DRUG FOR USE IN COMBINATION, AND USE THEREOF FOR PREPARING DRUGS FOR TREATMENT OF HIGH-GRADE BRAIN TUMORS IN RESPONSE TO INEFFECTIVE STANDARD TREATMENT FOR POSTOPERATIVE RECURRENCE
#6388L-THEANINE AND TETRAHYDROCANNABINOL FORMULATION
#6389Treatment of demyelinating disorders
#6390Nanocapsules comprising modified nucleobases and/or nucleosides, hydrogels and oleogels comprising them and uses thereof
#6391Biodegradable polymer formulations for extended efficacy of botulinum toxin
#6392FREEZE-DRIED FORMULATIONS OF ANTIBACTERIAL PROTEIN
#6393Dosing regimens for treatment of proliferative disorders
#6394Octreotide Depot Formulation with Constantly High Exposure Levels
#6395KIT FOR OPIOID OVERDOSE MONITORING
#6396TLR-9 AGONISTS FOR MODULATION OF TUMOR MICROENVIRONMENT
#6397RNA-AIDED IMMUNOTHERAPEUTICS
#6398Humanized BCMA antibody and BCMA-CAR-T cells
#6399Antibody Formulations
#6400Therapies and methods to treat TLR2-mediated diseases and disorders
#6401PROCESS FOR THE PREPARATION OF IRON (III) CARBOXYMALTOSE
#6402Electronic Smart Syringe
#6403Compositions of near IR closed chain, sulfo-cyanine dyes and prostate specific membrane antigen ligands
#6404CATIONIC NANOSTRUCTURES FOR INTRA-CARTILAGE DELIVERY OF THERAPEUTICS AND CONTRAST AGENTS
#6405Injectable composition
#6406BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
#6407Liquid delivery composition
#6408COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF INFECTIONS
#6409Placental Tissue Particulate Compositions and Methods of Use
#6410SEPSIS AND SEPTICEMIA TREATMENT PREPARATIONS USING LOW CONCENTRATION HYPOCHLOROUS ACID SOLUTIONS
#6411Polydextrose for the prevention and/or treatment of heart failure
#6412Compounds and compositions for treating solid tumors by intratumoral administration
#6413Methods of treating cancer
#6414Methods of treatment of cancer
#6415COMPOSITIONS AND METHODS FOR INHIBITING DIHYDROOROTATE DEHYDROGENASE
#6416Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
#6417Methods of treating lung cancer
#6418PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OF EPILEPSY-ASSOCIATED MOTOR SYMPTOM AND/OR COGNITIVE IMPAIRMENT
#6419Compositions and methods for treating defects in avascular cartilaginous tissue by directly administering one or more metabolites of simvastatin
#6420Methods of intravenous administration of glyburide
#6421Viral vectors and packaging cell lines
#6422Methods of inhibiting integrin α9β1 activity
#6423Therapeutic variant alpha-2-macroglobulin compositions
#6424Medical Delivery Devices With Inhibited Oxygen Permeation
#6425Stimulus-responsive micellar carrier
#6426CLOSTRIDIAL NEUROTOXIN FORMULATIONS AND USE
#6427METHOD OF REDUCING EGG CONTAMINATION
#6428COMPOSITIONS AND METHODS FOR TREATING DISEASES
#6429Skeletal muscle augmentation utilizing muscle-derived progenitor compositions, and treatments thereof
#6430MATERIALS AND METHODS FOR TREATING VITILIGO
#6431Materials and methods relating to stabilised polymeric silicate compositions
#6432COMPOSITION, FOR OSTEOARTHRITIS TREATMENT, COMPRISING HYDROPHILIZED SULFASALAZINE AND HYALURONIC ACID AND METHOD FOR PREPARING SAME
#6433HIGH-CONCENTRATION FULVESTRANT COMPOSITIONS
#6434Organic compounds
#6435Composition for protecting cardiomyocyte
#6436Single-dose, ready-to-use injectable formulations
#6437Compositions and methods for stimulating ventilatory and/or respiratory
#6438Stable Liquid Compositions of Melphalan
#6439CAPSAICINOIDS FOR USE IN TREATING ACRAL LICK GRANULOMA
#6440Injectable phenol formulations and methods of manufacture
#6441Injectable phenol formulations and methods of their use
#6442LOW THC HEMP EXTRACT AND METHOD OF TREATMENT OR PREVENTION OF AN EYE DISEASE
#6443NOVEL TREATMENT APPROACH BY TARGETED DELIVERY OF BIOACTIVE MOLECULES BIO MODULATED CERAMICS
#6444Pharmaceutical composition for intraarticular delivery
#6445Methods and compositions for sustained release microparticles for ocular drug delivery
#6446Neuromodulation for metabolic conditions or syndromes
#6447METHOD OF TREATING A MAMMAL WITH DIABETES ASSOCIATED KIDNEY DISEASE USING LOCAL ADMINISTRATION OF STEM CELLS WITH TRANSIENTLY REDUCED p53
#6448Methods of producing RPE cells
#6449Antibodies specific to glycosylated PD-1 and methods of use thereof
#6450DOSING REGIMEN FOR ANTI-BCMA AGENTS
#6451Removal of serine proteases by treatment with finely divided silicon dioxide
#6452Salt forms of a complement component C5A receptor
#6453Amorphous form of a complement component C5a receptor
#6454TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH AN IMMUNE MODULATORY AGENT RELEASED USING AN INGESTIBLE DEVICE
#6455Exon skipping oligomer conjugates for muscular dystrophy
#6456Exon skipping oligomer conjugates for muscular dystrophy
#6457Lyophilized formulation of long-acting human growth hormone immunoglobulin conjugate
#6458Methods for thrombolysis
#6459Dosage forms of tissue kallikrein 1
#6460Method for Treating or Preventing Radiotherapy-and Chemotherapy-Associated Oral Mucositis Using Locally Administered Heparin Binding Epidermal Growth Factor Like Growth Factor (HB-EGF)
#6461NON-ANTIBODY VEGF ANTAGONISTS FOR THE TREATMENT OF NEOVASCULAR GLAUCOMA
#6462Manufacture of degarelix
#6463Treatment for ischemic stroke
#6464MESENCHYMAL STROMAL CELL EXOSOMES AND USES THEREOF
#6465Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#6466COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CEREBRAL ATROPHY
#6467PHARMACEUTICAL COMPOSITIONS OF DECITABINE
#6468Drug combination for treatment of amyotrophic lateral sclerosis, preparation method and use thereof
#6469Pharmaceutical Composition for Treating Cerebral Infarction
#6470Administration of testosterone compositions
#6471SOLID PHARMACEUTICAL COMPOSITIONS COMPRISING BIOPTERIN DERIVATIVES AND USES OF SUCH COMPOSITIONS
#6472Liposomes Useful for Drug Delivery
#6473Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
#6474Bacterial efflux pump inhibitors
#6475CYSTEINE COMPOSITION AND INJECTION
#6476Composition and methods for treating intestinal hyperpermeability
#6477Ketamine and propofol admixture
#6478BIOMARKERS FOR NANOPARTICLE COMPOSITIONS
#6479Engineered tyrosine ammonia lyase
#6480Ischemic-lesion-site-specific gene therapy
#6481Bispecific antibody construct directed to MUC17 and CD3
#6482EGFL6 specific monoclonal antibodies and methods of their use
#6483Production of recombinant lubricin
#6484STRETCHABLE PLUNGER ASSEMBLIES
#6485DELIVERY DEVICE AND ADSORBENT
#6486Trifunctional constructs with tunablepharmacokinetics useful in imaging and anti-tumor therapies
#6487A pharmaceutical combination for use in the treatment of cancer
#6488CYTOTOXIC LIPID PARTICLES TARGETED TO TUMOR-ASSOCIATED MYELOID CELLS (TAMCS) AND SYNERGIZED WITH RADIATION THERAPY FOR TREATING GLIOBLASTOMA
#6489CGRP ANTAGONISTS AND CLOSTRIDIAL DERIVATIVES FOR THE TREATMENT OF CORTICAL SPREADING DEPRESSION ASSOCIATED DISORDERS
#6490IMMUNOMODULATORY THERAPEUTIC MRNA COMPOSITIONS ENCODING ACTIVATING ONCOGENE MUTATION PEPTIDES
#6491Method for managing pain
#6492METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 AND LOW MEAN ARTERIAL PRESSURE
#6493LHRH-PACLITAXEL CONJUGATES AND METHODS OF USE
#6494LHRH-CONJUGATED PRODIGIOSIN AND USES THEREOF
#6495Method of treating prostate cancer with GnRH antagonist
#6496Dosing regimens for echinocandin class compounds
#6497Composition for Regenerating Hepatic Tissue
#6498METHODS OF TREATING AUTISM SPECTRUM DISORDERS USING HUMAN UMBILICAL CORD TISSUE-DERIVED MESENCHYMAL STROMAL CELLS
#6499Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#6500Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#6501PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#6502Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#6503Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#6504Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#6505Radiation-Sterilized Biodegradable Drug Delivery Compositions
#6506INJECTABLE NEUROSTEROID FORMULATIONS CONTAINING NANOPARTICLES
#6507Treatment for Wolfram syndrome and other endoplasmic reticulum stress disorders
#6508Formulations for treatment of post-traumatic stress disorder
#6509INTRAVENOUS INFUSION DOSAGE FORM
#6510IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#6511Procaspase 3 activation by combination therapy
#6512Methods of treatment
#6513Treatment of skeletal-related events for breast cancer patients
#6514Compositions and methods for treating autism
#6515FORMULATION FOR USE IN A METHOD OF TREATMENT OF PAIN
#6516Pharmaceutical compositions of IL-2
#6517Drug Delivery Systems
#6518PROPOFOL FORMULATIONS WITH NON-REACTIVE CONTAINER CLOSURES
#6519Medical device to access pericardial space with control
#6520Methods of treating spinal cord injury using a chondroitin sulfate proteoglycan (CSPG) reduction peptide (CRP) comprising a cell membrane penetrating domain, a CSPG binding domain, and a lysosome targeting domain
#6521Long-acting injectable formulations and crystalline forms of buprenorphine derivatives
#6522METHODS OF REDUCING AGGREGATION OF IL-1RA
#6523Protein formulations and methods of making same
#6524LIQUID PHARMACEUTICAL COMPOSITION
#6525COMBINATION OF C-MET INHIBITOR WITH ANTIBODY MOLECULE TO PD-1 AND USES THEREOF
#6526CGRP Antagonists and Clostridial Derivatives for the Treatment of Neuropsychiatric and Neurological Disorders
#6527MODULATING RESPONSES TO CHECKPOINT INHIBITOR THERAPY
#6528Stable hybrid FC fusion G-CSF formulation
#6529COMPOSITIONS AND METHODS FOR TREATING SPINAL MUSCULAR ATROPHY
#6530Group B adenovirus-containing formulation
#6531COMPOSITIONS COMPRISING REGULATORY T CELLS AND METHODS OF MAKING AND USING THE SAME
#6532DEPOT FORMULATIONS
#6533Methotrexate for use as a medicament
#6534Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity
#6535Treprostinil prodrugs
#6536Lidocaine n-oxide for use in the prophylaxis of sudden cardiac death
#6537Immunomodulatory nanoparticle treatment of brain injury
#6538LIPID NANOPARTICLE COMPOSITIONS FOR DELIVERY OF MRNA AND LONG NUCLEIC ACIDS
#6539LIPID EMULSIONS AND USES THEREOF
#6540Succinylcholine prefilled syringe, compositions and methods
#6541THERAPEUTIC MODULATION OF TUMOR SUPPRESSORS USING EXOSOMES
#6542METHODS OF TREATING CHRONIC SPONTANEOUS URTICARIA USING LIGELIZUMAB
#6543Method of treating cancer with an anti-CCR8 that binds tumor infiltrating cells
#6544COMBINATION THERAPY WITH TARGETED TGF-B INHIBITION FOR TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER
#6545METHODS OF USING ANTI-CD79B IMMUNOCONJUGATES TO TREAT DIFFUSE LARGE B-CELL LYMPHOMA
#6546Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody
#6547METHODS FOR TREATING COMPLEMENT-MEDIATED DISEASES AND DISORDERS
#6548Method of producing recombinant high molecular weight vWF in cell culture
#6549MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE
#6550IGE EPITOPE-LIKE PEPTIDES AND USES THEREOF
#6551DIHYDRATE OF BENZOTHIOPHENE COMPOUND OR OF A SALT THEREOF, AND PROCESS FOR PRODUCING THE SAME
#6552Needle assisted injection device having reduced trigger force
#6553MEDICAL INFUSION PUMP SYSTEM FOR THE DELIVERY OF AN INSULIN COMPOUND
#6554EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS
#6555Protein formulations and methods of making same
#6556FORMULATION OF HUMAN ANTIBODIES FOR TREATING TNF-ALPHA ASSOCIATED DISORDERS
#6557METHOD OF PROVIDING SAFE ADMINISTRATION OF ADENOVIRAL VECTORS ENCODING A ZIKA VIRUS ANTIGEN
#6558Treatment of uterine fibroids using purified collagenase
#6559NEW USE OF CNF1
#6560Systems, methods and products for minimizing tissue reactions and tissue injury at an infusion site
#6561COMPOSITION COMPRISING THE EXTRACT OF HERBAL COMBINATION FOR PREVENTING OR TREATING DIABETIC PERIPHERAL NEUROPATHY
#6562SOMATIC STEM CELLS
#6563CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#6564Anesthetic pharmaceutical composition, system and method
#6565COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
#6566Method and compounds for treating peripheral neuropathy
#6567NANOPARTICULATE MELOXICAM FORMULATIONS
#6568Multikinase inhibitors of VEGF and TGF beta and uses thereof
#6569LIQUID FORMULATIONS OF BENDAMUSTINE
#6570Cationic polymers
#6571Poly (Alkyl Cyanoacrylate) Nanoparticles for Use in Treatment of Cancer
#6572Method for treatment of a leukocyte related disease by delivery of nucleic acid molecules to leukocytes using targeted lipid particles
#6573Products and Methods for Treatment of Familial Amyotrophic Lateral Sclerosis
#6574COMPOSITIONS COMPRISING EICOSAPENTAENOIC ACID AND MIPOMERSEN AND METHODS OF USE THEREOF
#6575GENE THERAPY FOR ALZHEIMER`S DISEASE
#6576Method for preparing acylated crosslinked glycosaminoglycans
#6577Methods of treating an eye disorder
#6578Subcutaneous formulations of anti-CD38 antibodies and their uses
#6579T-cell modulatory multimeric polypeptides and methods of use thereof
#6580COMPSTATIN ANALOGS FOR TREATMENT OF NEUROPATHIC PAIN
#6581Heterocyclic compound as CSF-1R inhibitor and use thereof
#6582Method and Kit for Treating Brain Tumor by using an Ultrasound System
#6583FORMULATIONS OF BENDAMUSTINE
#6584CD200 inhibitors and methods of use thereof
#6585COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES
#6586Pharmaceutical composition comprising plasminogen and uses thereof
#6587SYNERGISTIC COMBINATION OF CHEMOTHERAPY AND PEPTIDE FOR TREATING CANCER
#6588Food compositions and pharmaceutical compositions containing extract for lowering blood cholesterol levels and for ameliorating atherosclerosis
#6589Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#6590Morpholino oligonucleotides useful in cancer treatment
#6591INJECTABLE ANTIBIOTIC FORMULATIONS AND USE THEREOF
#6592Meloxicam composition, pharmaceutical preparation and preparation method and use thereof
#6593USE OF PRIDOPIDINE FOR THE TREATMENT OF ANXIETY AND DEPRESSION
#6594Use of melatonin for the treatment of tumors
#6595STABILIZED STATIN FORMULATIONS
#6596Compound antioxidant preparation for reducing the number of somatic cells in a livestock animal and a preparation method and application thereof
#6597PHARMACEUTICAL COMPOSITIONS AND METHODS
#6598Compositions, methods and uses of messenger RNA
#6599Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of CXCL9 and other biomarkers
#66006-pyrimidin-isoindole derivative as ERK1/2 inhibitor